StoneX Group’s Twist Bioscience TWST Stock Holding History

StoneX Group’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$287K	Buy	+1,868	New	+$231K	0.01%	1045

Other funds holding TWST

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Stephens Investment Management Group Houston, Texas $9.29B AUM 41.16% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $77.1B AUM 11.99% 1-Year Est. Return

StoneX Group's TWST Position: Q3 2026 in Review

StoneX Group opened a new position in Twist Bioscience (TWST) in Q3 2026: 1,868 shares worth $287K. The stake represents 0.01% of the portfolio and ranks #1045 among its holdings.

242 funds tracked by Wall St. Rank hold TWST as of Q3 2026.

StoneX Group held 1,868 shares of Twist Bioscience worth $287K as of Q3 2026.
Twist Bioscience was a new StoneX Group position in Q3 2026.
Twist Bioscience made up 0.01% of StoneX Group's portfolio in Q3 2026, its #1045 holding.
242 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2026.

Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.